AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 151 min read$SNES

Edell Michael purchased $840 of SNES

Edell Michael (Chief Executive Officer) purchased 1,000 shares of SenesTech, Inc. (SNES) at $0.84 on 2026-09-14.

Original reporting
SEC EDGAR · Edell Michael
Published Sep 15, 2026, 8:26 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 8:45 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$SNES
Neutral
low confidence
Mentioned
$SNES
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SNESNeutralLow
01

Why it matters

The purchase is minor and unlikely to affect market perception or price.

02

Market read

Limited relevance; only of interest to insiders tracking insider activity.

03

What to watch

Potential upcoming corporate events not disclosed could make the purchase more relevant.

Relevance 4/10Novelty 4/10Timing: filed Sep 15 2026

Background

Form 4 filings disclose insider trades; investors monitor them for signals of confidence.

Company-level read

Ticker impact

$SNESNeutralLow confidence
Context

CEO Edell Michael bought 1,000 shares of SenesTech, Inc. for $840 in a Form 4 filing.

Expected impact

Minimal impact; may signal slight confidence but negligible price change.

Evidence & confidence

Purchase size is tiny relative to market cap and typical trading volume; no material effect.

Market effects

Sector

None; insider activity does not affect broader biotech sector.

Regional

None; transaction is company‑specific.

Global

None

Counterpoint

What could challenge this read

The purchase is too small to indicate meaningful confidence; could be routine compensation.

Key entities

  • Company
    SenesTech, Inc.

    Biotech firm whose ticker is SNES.

  • Person
    Edell Michael

    Chief Executive Officer of SenesTech.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

SNES insider trading history →

Related articles

AUG 5
$SNESMed

SenesTech, Inc. (SNES): Results of Operations and Financial Condition

SenesTech, Inc. (SNES) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SenesTech Reports Record Q2 2026 Revenue and Gross Margin as E-commerce Growth Accelerates Revenue rose 56% sequentially and gross margin reached a company-record 73.6% in the first full quarter of in-house Amazon management, advancing the Company’s intended shift to

SEC EDGAR 8-K6 min
AUG 3
$SNESLow

SenesTech, Inc. (SNES): Results of Operations and Financial Condition

SenesTech, Inc. (SNES) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SenesTech Active Subscriber Base More Than Doubles as E-commerce Strategy Gains Momentum Integrated e-commerce strategy drives recurring revenue while supporting long-term growth across consumer and business-to-business markets. SURPRISE, Ariz., Aug. 3, 2026 — SenesT

SEC EDGAR 8-K2 min